Advocate Group’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
Other funds holding MDT
FWIA
GAM
SRIM
DC
Advocate Group's MDT Position: Q2 2026 in Review
Advocate Group increased its Medtronic (MDT) stake by 13% in Q2 2026, buying an estimated $1.21M and bringing the position to 126,604 shares worth $9.9M. The position accounts for 1.49% of the portfolio, ranked #23.
Advocate Group first reported a position in MDT in Q2 2022 and has held it in 17 quarters since. The position peaked at $10.9M in Q3 2025. 961 funds tracked by Wall St. Rank hold MDT as of Q2 2026.
- Advocate Group held 126,604 shares of Medtronic worth $9.9M as of Q2 2026.
- Advocate Group bought 14,942 Medtronic shares in Q2 2026, an estimated $1.21M.
- Medtronic made up 1.49% of Advocate Group's portfolio in Q2 2026, its #23 holding.
- Advocate Group first reported a position in Medtronic in Q2 2022 and has held it in 17 quarters since.
- Advocate Group's Medtronic position peaked at $10.9M in Q3 2025.
- 961 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.
Based on Advocate Group's 13F filing for Q2 2026, filed 17 Jul 2026.